David Tuller (University of California, Berkeley), Steven Lubet (Northwestern University), and I have written an opinion piece over at Health Affairs. It’s on the implications of recent developments in ME and chronic fatigue syndrome for the treatment of Long COVID. We argue that the paradigm shift signalled by the UK’s […]
myalgic encephalomyelitis
All Aboard the Long COVID gravy train
Swiss Re Group, “one of the world’s leading providers of reinsurance and insurance,” recently hosted a virtual Expert Forum on “secondary” impacts of COVID. As would be expected, the insurance industry is especially interested in the financial implications of this new disease. The programme covered many of the biophysical sequelae […]
Beware the COVID-sceptic doctors
It turns out that not all medical doctors are infallible. Who knew? Some of them, it seems, dally at the margins of pseudoscience. Take for example the latest BMJ Op-Ed from the doctor who cured himself of long COVID. He says he did so through positive thinking. Go him! ‘Pseudoscience’ is […]
Letter to the BMJ
David Tuller, Vincent Racaniello, and I have written to the BMJ about that guest editorial on the draft NICE guidelines for ME and related conditions. The letter is also online over at Virology Blog and has now been posted as a Rapid Response on BMJ.com. * * * Subject line: […]
No More Mr NICE Guy…
The newly released draft NICE guidelines for the management of “myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome” continue to cause a stir. And rightly so. The new guidelines not only repudiate a heretofore favoured treatment approach for a particular illness, they also threaten to discredit an entire (albeit quirky) branch of […]
Why conduct good research when you can just cock it all up?
Here’s a video of my talk from last year at the Sheffield ME and Fibromyalgia Group Autumn Conference: Thanks are due to Carol Binks and colleagues in Sheffield for recording the event. They even recorded the Q&A, which you can see over on YouTube. Enjoy!